Month: September 2014

Recent Issues of Bentham Science Journals have been Published

Inflammation & Allergy-Drug Targets, 13 Issue 4

Aims & scope

Inflammation & #Allergy – Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular targets involved in inflammation and allergy e.g. disease specific proteins, receptors, enzymes, genes. The journal publishes expert in-depth reviews, original research articles, drug clinical trial studies and guest edited thematic issues covering a range of current topics on drug targets involved in inflammation and allergy. As the discovery, identification, characterization and validation of novel human drug targets for anti-inflammation and allergy drug discovery continue to grow; this journal has become essential reading for all pharmaceutical scientists involved in drug discovery and development.

http://www.eurekaselect.com/124592/issue/4

Abstracted & Indexed in

Chemical Abstracts, BIOSIS, BIOSIS Previews, BIOSIS Reviews Reports and Meetings, MEDLINE/Index Medicus, EMBASE/ExcerptaMedica, Scopus, PubsHub, GenamicsJournalSeek, MediaFinder®-Standard Periodical Directory, and J-Gate..

For details about the latest issues, visit:http://benthamscience.com/journal/index.php?journalID=iadt

 

Current Topics in Medicinal Chemistry, 14 Issue 14

Aims & scope

Current Topics in Medicinal Chemistry is a forum for the review of areas of keen and topical interest to medicinal chemists and others in the allied disciplines. Each issue is solely devoted to a specific topic, containing six to nine reviews, which provide the reader a comprehensive survey of that area. A Guest Editor who is an expert in the topic under review, will assemble each issue. The scope of Current Topics in Medicinal Chemistry will cover all areas of medicinal chemistry, including current developments in rational drug design, synthetic chemistry, bioorganic chemistry, high-throughput screening, combinatorial chemistry, compound diversity measurements, drug absorption, drug distribution, metabolism, new and emerging drug targets, natural products, pharmacogenomics, and structure-activity relationships. Medicinal chemistry is a rapidly maturing discipline. The study of how structure and function are related is absolutely essential to understanding the molecular basis of life. Current Topics in Medicinal Chemistry aims to contribute to the growth of scientific knowledge and insight, and facilitate the discovery and development of new therapeutic agents to treat debilitating human disorders. The journal is essential for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important advances.

http://www.eurekaselect.com/124602/issue/14

Abstracted & Indexed in

BIOSIS, Chemical Abstracts, MEDLINE/Index Medicus, PUBMED, ISI, Science Citation Index ExpandedTM, Biochemistry & Biophysics Citation IndexTM, index to Scientific Reviews®, Current Contents®, EMBASE/ExcerptaMedica, Journal Citation Reports/Science Edition, BIOSIS Previews, BIOSIS Reviews Reports and Meetings, Scopus, GenamicsJournalSeek, MediaFinder®-Standard Periodical Directory, PubsHub, and J-Gate.

For details about the latest issues, visit:http://benthamscience.com/journal/index.php?journalID=ctmc

 

Mini-Reviews in Organic Chemistry, 11 Issue 3

Aims & scope

Current Topics in Medicinal Chemistry is a forum for the review of areas of keen and topical interest to medicinal chemists and others in the allied disciplines. Each issue is solely devoted to a specific topic, containing six to nine reviews, which provide the reader a comprehensive survey of that area. A Guest Editor who is an expert in the topic under review, will assemble each issue. The scope of Current Topics in Medicinal Chemistry will cover all areas of medicinal chemistry, including current developments in rational drug design, synthetic chemistry, bioorganic chemistry, high-throughput screening, combinatorial chemistry, compound diversity measurements, drug absorption, drug distribution, metabolism, new and emerging drug targets, natural products, pharmacogenomics, and structure-activity relationships. Medicinal chemistry is a rapidly maturing discipline. The study of how structure and function are related is absolutely essential to understanding the molecular basis of life. Current Topics in Medicinal Chemistry aims to contribute to the growth of scientific knowledge and insight, and facilitate the discovery and development of new therapeutic agents to treat debilitating human disorders. The journal is essential for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important advances.

http://www.eurekaselect.com/124555/issue/3

Abstracted & Indexed in

BIOSIS, Chemical Abstracts, MEDLINE/Index Medicus, PUBMED, ISI, Science Citation Index ExpandedTM, Biochemistry & Biophysics Citation IndexTM, index to Scientific Reviews®, Current Contents®, EMBASE/ExcerptaMedica, Journal Citation Reports/Science Edition, BIOSIS Previews, BIOSIS Reviews Reports and Meetings, Scopus, GenamicsJournalSeek, MediaFinder®-Standard Periodical Directory, PubsHub, and J-Gate

For details about the latest issues, visit:http://benthamscience.com/journal/index.php?journalID=ctmc

 

Current Inorganic Chemistry, 4 Issue 2

Aims & scope

Current Inorganic #Chemistry, a peer-reviewed journal, publishing original research, review articles and guest edited thematic issues in all areas of inorganic chemistry. The journal’s scope includes the synthesis, crystal structure, physical methods, thermodynamics, reactivity, spectroscopy, electronic and bonding properties of significant new and known (bio) inorganic and organometallic compounds.

Current Inorganic Chemistry is an important and reliable source of information on current developments, research and theory in the field. The emphasis is on publishing high quality articles.

http://www.eurekaselect.com/124573/issue/2

Abstracted & Indexed in

Chemical Abstracts, MediaFinder®-Standard Periodical Directory, and J-Gate.

For details about the latest issues, visit: http://benthamscience.com/journal/index.php?journalID=cic

 

Current Drug Targets, 15 Issue 10

Aims & scope

Current Drug Targets aims to cover the latest and most outstanding developments on the medicinal chemistry and pharmacology of molecular drug targets e.g. disease specific proteins, receptors, enzymes, genes.

Current Drug Targets publishes guest edited thematic issues written by leaders in the field covering a range of current topics of drug targets. The journal also accepts for publication mini- & full-length review articles and drug clinical trial studies.

As the discovery, identification, characterization and validation of novel human drug targets for drug discovery continues to grow; this journal is essential reading for all pharmaceutical scientists involved in drug discovery and development.

http://www.eurekaselect.com/124609/issue/10

Abstracted & Indexed in

#ChemicalAbstracts, BIOSIS Previews, BIOSIS Reviews Reports and Meetings, Science Citation Index Expanded® (Sci Search), Index to Scientific Reviews®, Biochemistry & Biophysics Citation Index®, PUBMED, BIOSIS, Journal Citation Reports/Science Edition, EMBASE/ExcerptaMedica, MediaFinder-Standard Periodical Directory, Medline, Scopus, EMBASE, Genamics Journal Seek, PubsHub, and J-Gate.

For details about the latest issues, visit: http://benthamscience.com/journal/index.php?journalID=cdt

 

Current Molecular Imaging, 3 Issue 1

Aims & scope

Current Molecular Imaging publishes peer reviewed expert review articles and special topic issues on all aspects of experimental and clinical research in molecular imaging. Topics include the investigative and practical applications of novel radiopharmaceuticals; standard and complicated imaging methodologies and probes; as well as standard and evolving quantitative approaches.

http://www.eurekaselect.com/124654/issue/1

Abstracted & Indexed in

Chemical Abstracts, J-Gate, PubsHub, and Scopus.

For details about the latest issues, visit: http://benthamscience.com/journal/index.php?journalID=cmi

 

Recent Patents on Anti-Infective Drug Discovery, 9 Issue 1

Aims & scope

Recent Patents on Anti-Infective Drug Discovery publishes review and research articles, drug clinical trial studies and guest edited thematic issues on recent patents in the field of anti-infective drug discovery e.g. on novel bioactive compounds, analogs & targets. A selection of important and recent patents on anti-infective drug discovery is also included in the journal. The journal is essential reading for all researchers involved in anti-infective drug design and discovery. The journal also covers recent research (where patents have been registered) in fast emerging therapeutic areas/targets & therapeutic agents related to anti-infective drug discovery.

http://www.eurekaselect.com/124637/issue/1

Abstracted & Indexed in

PubMed/Medline, Scopus, EMBASE, METADEX, CAB Abstracts, Cambridge Scientific Abstracts (CSA), Chemical Abstracts, GenamicsJournalSeek, MediaFinder®-Standard Periodical Directory, PubsHub, and J-Gate.

For details about the latest issues, visit:http://benthamscience.com/journal/index.php?journalID=rpaidd

UPCOMING PATENT EBOOK SERIES

Volume 3, 2014 of the Patent e-Book Series “Topics in Anti-Cancer-Research” has been lined up and will be available online soon.

Amazing Discount Offers!!

ebooks

View our #ebook collections here:

http://ebooks.benthamscience.com/bookshelf-by-subject/D1/

To learn more, contact us at ebooks@benthamscience.org.

Major Article Contributions by some of the Indian Authors in Bentham Science Publishers Journal; Protein & Peptide Letters

Article Title:Antiangiogenic Function of Antithrombin is Dependent on its Conformational Variation: Implication for Other Serpins

Author(s): Asim Azhar, Poonam Singh, Qudsia Rashid, Asma Naseem, Mohammad Sazzad Khan and Mohamad Aman Jairajpuri

 

Abstract: Endogenous angiogenesis inhibitor that specifically decreases tumor cell proliferation can be used to treat cancer since angiogenesis is required at every step of tumor progression and metastasis. Endothelial cells are the main target for the antiangiogenic therapy because they are non-transformed and easily accessible to angiogenic inhibitors. Antithrombin functions as a principal plasma protein inhibitor of blood coagulation proteinases and belongs to the family of serine protease inhibitors (serpins) which have common mechanism of inhibition. Antithrombin acquires a potent antiangiogenic activity upon conversion of the native molecule to cleaved or latent conformation. Cleaved and latent preparations of bovine and human plasma derived antithrombin inhibited capillary endothelial cell proliferation and the growth of human SK-NAS neuroblastoma and Lewis lung carcinoma tumors in mice as compared to the native antithrombin. The native form of antithrombin binds with high affinity to vascular heparan sulfate proteoglycans containing a specific pentasaccharide sequence and it is this cofactor interaction that activated antithrombin to maximal rate of thrombin inhibition. Upon inhibitory complex formation with target proteinases the antithrombin undergoes stressed to relaxed transformation and lose their high affinity for pentasacchride. Low affinity relaxed conformation with reduced heparin binding like cleaved and latent are antiangiogenic but native high affinity heparin binding stressed conformation is not, indicating the critical importance of heparin affinity in antithrombin antiangiogenic function. Based on evidence of interactions of the endothelial cell growth factors bFGF (Basic fibroblast growth factor) and VEGF (vascular endothelial cell growth factor) with heparin like molecule in matrix, the possibility of antiangiogenic antithrombin to interfere with endothelial cell growth and angiogenesis through heparin mediated mechanism deserves serious consideration and investigation. It is also possible that cleaved and latent conformations with reduced affinity for heparins can also induce conformational change in the antithrombin which can open an epitope on the antithrombin surface for appropriate interactions on the endothelial surface for better antiangiogenic activity. This review illustrates the potential of antithrombin and other serpin family members as endogenous antiangiogenic proteins.

For more details, visit: http://benthamscience.com/journal/abstracts.php?journalID=ppl&articleID=103876

 

Article Title:X-Ray Structure of PTP1B in Complex with a New PTP1B Inhibitor

Author(s): M.V.V.V. Sekhar reddy, Chakshumathi Ghadiyaram, Sunil Kumar Panigrahi, Narasimha Rao Krishnamurthy, Subramanya Hosahalli, Arun P. Chandrasekharappa, Deepankar Manna, Sangamesh E. Badiger, Pramod K. Dubey and Lakshmi Narasu Mangamoori

Abstract: Protein tyrosine phosphatase 1B (PTP1B) is a prototype non receptor cytoplasmic PTPase enzyme that has been implicated in regulation of insulin and leptin signaling pathways. Studies on PTP1B knockout mice and PTP1B antisense treated mice suggested that inhibition of PTP1B would be an effective strategy for the treatment of type II diabetes and obesity. Here we report the X-ray structure of PTP1B in complex with compound IN1834-146C (PDB ID 4I8N). The crystals belong to P3121 space group with cell dimensions (a = b = 87.89 Å, c = 103.68 Å) diffracted to 2.5 Å. The crystal structure contained one molecule of protein in the asymmetric unit and was solved by molecular replacement method. The compound engages both catalytic site and allosteric sites of PTP1B protein. We described the molecular interaction of the compound with the active site residues of PTP1B in this crystal structure report.

For more details, visit: http://benthamscience.com/journal/abstracts.php?journalID=ppl&articleID=114408

 

Article Title:The Solubility and Stability of Amino Acids in Biocompatible Ionic Liquids

Author(s): T. Vasantha, Awanish Kumar, Pankaj Attri, Pannuru Venkatesu and R.S. Rama Devi

Abstract: In recent years, ionic liquids (ILs) represent a new class of biocompatible co-solvents for biomolecules. In this work, we report the apparent transfer free energies ( ΔG’tr) for six amino acids (AA) from water to aqueous solutions of six ammonium based ILs (diethylammonium acetate (DEAA), diethylammonium sulfate (DEAS), triethyl ammonium acetate (TEAA), triethylammonium sulfate (TEAS), triethylammonium dihydrogen phosphate (TEAP), and trimethylammonium acetate (TMAA)) through solubility measurements, as a function of IL concentration at 298.15 K under atmospheric pressure. Salting-out effect was found for AA in aqueous IL solutions with increasing IL concentrations. In addition, we observed positive values of Δ G’tr for AA from water to ILs, indicating that the interactions between ILs and AA are unfavorable. From the obtained results, we found that the selected ammonium based ILs act as stabilizers for the structure of AA.

For more details, visit: http://benthamscience.com/journal/abstracts.php?journalID=ppl&articleID=113378

 

Article Title:Purification and Biophysical Characterization of an 11S Globulin from Wrightia tinctoria Exhibiting Hemagglutinating Activity

Author(s): Pramod Kumar, Dipak N. Patil, Anshul Chaudhary, Shailly Tomar, Dinesh Yernool, Nirpendra Singh, Pushpanjali Dasauni, Suman Kundu and Pravindra Kumar

Abstract: Wrightia tinctoria globulin (WTG), one of the major seed storage proteins, was isolated for the first time from seeds of the medicinal plant. WTG was extracted and purified to homogeneity in two steps using anion-exchange and size-exclusion chromatographies. On an SDS–PAGE gel under non-reducing conditions, a major band of ~56 kDa was observed; under reducing conditions, however, two major polypeptides, one with molecular weight ~32-34 kDa and the other with molecular weight ~22-26 kDa were observed. Intact mass determination by MALDI-TOF supported this observation. The N-terminal amino acid sequence of WTG matched in NCBI database with an expressed sequence tag obtained from the c-DNA of developing embryo m-RNA of Wrightia tinctoria. The EST sequence was further substantiated by partial de novo internal sequencing using MALDI-TOF/TOF. The high sequence homology with seed storage protein 11S globulin confirmed that WTG is a type of 11S globulin. Circular dichroism analysis showed that the secondary structure of WTG consists predominantly of β-sheets (44.2%) and moderate content of α-helices (10.3%). WTG showed hemagglutinating property indicating that the protein may possess lectin-like activity. WTG was crystallized at 20 °C by the vapour diffusion method using PEG 400 as precipitant. The crystals belonged to the orthorhombic space group P212121 with cell dimensions of a=109.9Å, b=113.2Å and c=202.2Å with six molecules per asymmetric unit. Diffraction data were collected to a resolution of 2.2Å under cryocondition. Preliminary structure solution of WTG indicated the possibility of a hexameric assembly in its asymmetric unit.

For more details, visit: http://benthamscience.com/journal/abstracts.php?journalID=ppl&articleID=108419

Surgical Inflammation- Book Review

9781608057856-1

Bentham Science Publishers #eBook

Surgical Inlammation

Surgical Inflammation, edited by Arias, Aller and Arias, is a series of in-depth review chapters pertaining to the discussion of inflammation as it applies to surgery. This Spanish grouping has a long standing interest in the topics discussed and use the present textbook to present their own viewpoints and hypotheses on the principles underlying the inflammatory response. The book itself is fairly wordy with interspersed hand-drawn (yet attractive) diagrams detailing the processes described. Chapter titles include “Embryological basis of inflammation”,”The polytraumatized patient” and “Cancer: using the inflammatory way”, with up to 200 references per chapter. The text is at times dramatic and intriguing with section titles including “Mast cells as executors of the pathological axis of inflammation:  Guardians when not Terrorists” and “The inflammatory interstitium behaves like an endothelial egg”. The initial chapters (2-4) describe several different but valid descriptions of the phases of the inflammatory response, including the nervous, immune and endocrine phases and the colours of the inflammatory response. The authors clearly believe embryological principles underpin a great deal of the processes described and this is a theme throughout. Ultimately this is an interesting read and a substantial body of work from an established grouping. However, the content is fairly specific and not particularly useful for clinicians seeking a general overview of the topic.

Reviewed by: C Roxburgh – Glasgow Royal Infirmary, The British Journal of Surgery, Wiley / 27 June 2014

For detials, visit to: http://www.bjs.co.uk/details/book/6330611/Surgical-Inflammation.html

http://ebooks.benthamscience.com/

Highlighted Article Of the Journal: Current Gene Therapy

CGT-Articles

For details visit: http://benthamscience.com/journal/index.php?journalID=cgt

Bentham Science Publishers- News Release:

Chemical Abstracts Service (CAS) Indexes Current Microwave Chemistry and Current Organocatalysis

Bussum, Netherlands, 18 September 2014: Chemical Abstracts Service, a division of the American Chemical Society accepts to index two new journals  Current Microwave Chemistry and Current Organocatalysis published by Bentham Science Publishers.

Current Microwave Chemistry is an international peer-reviewed journal that publishes important contributions describing advances in the use of the microwave across the field of in chemistry, biology, medicine, biomedical science, and engineering.

For details, please visit the journal website at:  http://benthamscience.com/journal/aims-scope.php?journalID=cmic

Current Organocatalysis is an international peer-reviewed journal that publishes significant research in all areas of organocatalysis. The journal covers organo homogeneous/heterogeneous catalysis, innovative mechanistic studies and kinetics of organocatalysis processes focusing on practical, theoretical and computational aspects.

For details, please visit the journal website at: http://benthamscience.com/journal/index.php?journalID=cocat

Bentham Science Launches “Clinical Immunology, Endocrine & Metabolic Drugs”

Bentham Science is pleased to announce the launch of a new journal, Clinical Immunology, Endocrine & Metabolic Drugs. The inaugural journal issue is available online for free access via: Clinical Immunology, Endocrine & Metabolic Drugs

Clinical Immunology, Endocrine & Metabolic Drugs publishes original research, expert reviews, drug clinical trials and thematic issues in all core areas of translational and clinical immunology, endocrine & metabolic drug research. The journal is available in both electronic and print editions.

For more details please visit the journal website Clinical Immunology, Endocrine & Metabolic Drugs

 

Recent Issues of Bentham Science Journals have been Published

Current Pharmaceutical Design, 20 Issue 33

Aims & scope                         

Current Pharmaceutical Design publishes timely in-depth reviews and research articles from leading pharmaceutical researchers in the field, covering all aspects of current research in rational drug design. Each issue is devoted to a single major therapeutic area guest edited by an acknowledged authority in the field.

Each thematic issue of Current Pharmaceutical Design covers all subject areas of major importance to modern drug design including: medicinal chemistry, pharmacology, drug targets and disease mechanism.

http://www.eurekaselect.com/124503/issue/33

Abstracted & Indexed in

Biochemistry & Biophysics Citation Index®, BIOSIS, Chemical Abstracts, Current Contents®/Life Sciences, EMBASE/ExcerptaMedica, MEDLINE/Index Medicus, Medical Documentation Service®, Research Alert®, Science Citation Index®, Science Citation Index Expanded (SciSearch®), Cambridge Scientific Abstracts (CSA), PubsHub, Journal Citation Reports/Science Edition, Index to Scientific Reviews®, Custom Information Services®, BIOSIS Previews, BIOSIS Reviews Reports and Meetings, Scopus, GenamicsJournalSeek, and J-Gate.

For details about the latest issues, visit:http://benthamscience.com/journal/index.php?journalID=cpd

 

Current Pharmaceutical Design, 20 Issue 32

Aims & scope

Current Pharmaceutical Design publishes timely in-depth reviews and research articles from leading pharmaceutical researchers in the field, covering all aspects of current research in rational drug design. Each issue is devoted to a single major therapeutic area guest edited by an acknowledged authority in the field.

Each thematic issue of Current Pharmaceutical Design covers all subject areas of major importance to modern drug design including: medicinal chemistry, pharmacology, drug targets and disease mechanism.

http://www.eurekaselect.com/124461/issue/32

Abstracted & Indexed in

Biochemistry & Biophysics Citation Index®, BIOSIS, Chemical Abstracts, Current Contents®/Life Sciences, EMBASE/ExcerptaMedica, MEDLINE/Index Medicus, Medical Documentation Service®, Research Alert®, Science Citation Index®, Science Citation Index Expanded (SciSearch®), Cambridge Scientific Abstracts (CSA), PubsHub, Journal Citation Reports/Science Edition, Index to Scientific Reviews®, Custom Information Services®, BIOSIS Previews, BIOSIS Reviews Reports and Meetings, Scopus, GenamicsJournalSeek, and J-Gate.

For details about the latest issues, visit: http://benthamscience.com/journal/index.php?journalID=cpd

 

Current Pharmaceutical Design, 20 Issue 34

Aims & scope

Current Pharmaceutical Design publishes timely in-depth reviews and research articles from leading pharmaceutical researchers in the field, covering all aspects of current research in rational drug design. Each issue is devoted to a single major therapeutic area guest edited by an acknowledged authority in the field.

Each thematic issue of Current Pharmaceutical Design covers all subject areas of major importance to modern drug design including: medicinal chemistry, pharmacology, drug targets and disease mechanism.

http://www.eurekaselect.com/124507/issue/34

Abstracted & Indexed in

Biochemistry & Biophysics Citation Index®, BIOSIS, Chemical Abstracts, Current Contents®/Life Sciences, EMBASE/ExcerptaMedica, MEDLINE/Index Medicus, Medical Documentation Service®, Research Alert®, Science Citation Index®, Science Citation Index Expanded (SciSearch®), Cambridge Scientific Abstracts (CSA), PubsHub, Journal Citation Reports/Science Edition, Index to Scientific Reviews®, Custom Information Services®, BIOSIS Previews, BIOSIS Reviews Reports and Meetings, Scopus, GenamicsJournalSeek, and J-Gate.

For details about the latest issues, visit: http://benthamscience.com/journal/index.php?journalID=cpd

 

Current Pharmaceutical Design, 20 Issue 35

Aims & scope

Current Pharmaceutical Design publishes timely in-depth reviews and research articles from leading pharmaceutical researchers in the field, covering all aspects of current research in rational drug design. Each issue is devoted to a single major therapeutic area guest edited by an acknowledged authority in the field.

Each thematic issue of Current Pharmaceutical Design covers all subject areas of major importance to modern drug design including: medicinal chemistry, pharmacology, drug targets and disease mechanism.

http://www.eurekaselect.com/124508/issue/35

Abstracted & Indexed in

Biochemistry & Biophysics Citation Index®, BIOSIS, Chemical Abstracts, Current Contents®/Life Sciences, EMBASE/ExcerptaMedica, MEDLINE/Index Medicus, Medical Documentation Service®, Research Alert®, Science Citation Index®, Science Citation Index Expanded (SciSearch®), Cambridge Scientific Abstracts (CSA), PubsHub, Journal Citation Reports/Science Edition, Index to Scientific Reviews®, Custom Information Services®, BIOSIS Previews, BIOSIS Reviews Reports and Meetings, Scopus, GenamicsJournalSeek, and J-Gate.

For details about the latest issues, visit: http://benthamscience.com/journal/index.php?journalID=cpd

 

Current Inorganic Chemistry, 4 Issue 1

Aims & scope

Current Inorganic Chemistry, a peer-reviewed journal, publishing original research, review articles and guest edited thematic issues in all areas of inorganic chemistry. The journal’s scope includes the synthesis, crystal structure, physical methods, thermodynamics, reactivity, spectroscopy, electronic and bonding properties of significant new and known (bio) inorganic and organometallic compounds.

Current Inorganic Chemistry is an important and reliable source of information on current developments, research and theory in the field. The emphasis is on publishing high quality articles.

http://www.eurekaselect.com/124511/issue/1

Abstracted & Indexed in

Chemical Abstracts, MediaFinder®-Standard Periodical Directory, and J-Gate.

For details about the latest issues, visit: http://benthamscience.com/journal/index.php?journalID=cic

 

Bentham Science Publishers Free 3 Months Trial Is Active In:

University: Beijing University of Chemical Technology

About the university:

Beijing University of Chemical Technology (BUCT) was founded in 1958 and is affiliated to the Ministry of Education. As one of China’s key institutions of higher learning, BUCT has developed from an institution of scientific specialties to a comprehensive university with a core curriculum of science, economic management, languages and other liberal arts.

http://www.at0086.com/BICT/

Technology Transfer and Entrepreneurship Journal signed agreement with the Society of Physician Entrepreneurs (SOPE):

News release date: August 30, 2014

Bentham Science is pleased to offer a discounted price for 2014 subscription (Online) to the journal Technology Transfer and Entrepreneurship for all members of the Society of Physician Entrepreneurs.

Society of Physician Entrepreneurs (SOPE) is a global biomedical and healthcare innovation network dedicated to create a global community that accelerates medical innovation to patients around the world.

Technology Transfer and Entrepreneurship (TTE) publishes definitive review articles including case histories covering a broad range of topics that underlie the business of biomedical and research, specifically translating basic scientific discoveries into commercial opportunities. The Journal’s website: http://benthamscience.com/journal/index.php?journalID=tte